These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31344424)

  • 1. Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles.
    Sousa F; Dhaliwal HK; Gattacceca F; Sarmento B; Amiji MM
    J Control Release; 2019 Sep; 309():37-47. PubMed ID: 31344424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nanoencapsulation using poly (lactide-co-glycolide) (PLGA) on anti-angiogenic activity of bevacizumab for ocular angiogenesis therapy.
    Zhang XP; Sun JG; Yao J; Shan K; Liu BH; Yao MD; Ge HM; Jiang Q; Zhao C; Yan B
    Biomed Pharmacother; 2018 Nov; 107():1056-1063. PubMed ID: 30257317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic-
    Banstola A; Duwa R; Emami F; Jeong JH; Yook S
    Mol Pharm; 2020 Nov; 17(11):4386-4400. PubMed ID: 33079558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorotoxin modified morusin-PLGA nanoparticles for targeted glioblastoma therapy.
    Agarwal S; Mohamed MS; Mizuki T; Maekawa T; Sakthi Kumar D
    J Mater Chem B; 2019 Oct; 7(39):5896-5919. PubMed ID: 31423502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of Cholera Toxin Subunit B Functionalized Nanoparticles for Targeted Therapy of Glioblastoma.
    Guan J; Qian J; Zhan C
    Methods Mol Biol; 2020; 2059():207-212. PubMed ID: 31435923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles.
    Sousa F; Cruz A; Fonte P; Pinto IM; Neves-Petersen MT; Sarmento B
    Sci Rep; 2017 Jun; 7(1):3736. PubMed ID: 28623267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
    Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verteporfin-Loaded Polymeric Microparticles for Intratumoral Treatment of Brain Cancer.
    Shah SR; Kim J; Schiapparelli P; Vazquez-Ramos CA; Martinez-Gutierrez JC; Ruiz-Valls A; Inman K; Shamul JG; Green JJ; Quinones-Hinojosa A
    Mol Pharm; 2019 Apr; 16(4):1433-1443. PubMed ID: 30803231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal delivery of cancer-targeting doxorubicin-loaded PLGA nanoparticles arrests glioblastoma growth.
    Chung K; Ullah I; Kim N; Lim J; Shin J; Lee SC; Jeon S; Kim SH; Kumar P; Lee SK
    J Drug Target; 2020 Jul; 28(6):617-626. PubMed ID: 31852284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan coated nanoparticles for efficient delivery of bevacizumab in the posterior ocular tissues via subconjunctival administration.
    Pandit J; Sultana Y; Aqil M
    Carbohydr Polym; 2021 Sep; 267():118217. PubMed ID: 34119171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI.
    Cho HR; Kumari N; Thi Vu H; Kim H; Park CK; Choi SH
    Sci Rep; 2019 Jul; 9(1):11085. PubMed ID: 31366997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Dendrimer-Cationized-Albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin.
    Muniswamy VJ; Raval N; Gondaliya P; Tambe V; Kalia K; Tekade RK
    Int J Pharm; 2019 Jan; 555():77-99. PubMed ID: 30448308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy.
    Ramalho MJ; Serra É; Lima J; Loureiro JA; Pereira MC
    Eur J Pharm Biopharm; 2024 Jul; 200():114326. PubMed ID: 38759897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications.
    Liu J; Zhang X; Li G; Xu F; Li S; Teng L; Li Y; Sun F
    Int J Nanomedicine; 2019; 14():8819-8834. PubMed ID: 31819410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral VEGF nanotrapper reduces gliobastoma vascularization and tumor cell mass.
    Sousa F; Costa-Pereira AI; Cruz A; Ferreira FJ; Gouveia M; Bessa J; Sarmento B; Travasso RDM; Mendes Pinto I
    J Control Release; 2021 Nov; 339():381-390. PubMed ID: 34592385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
    Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
    Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus loaded chitosan functionalized poly (lactic-co-glycolic acid) (PLGA) nanoparticles for potential treatment of age-related macular degeneration.
    Suri R; Neupane YR; Mehra N; Nematullah M; Khan F; Alam O; Iqubal A; Jain GK; Kohli K
    Int J Biol Macromol; 2021 Nov; 191():548-559. PubMed ID: 34536476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Angiogenics: Their Role in the Treatment of Glioblastoma.
    Winkler F; Osswald M; Wick W
    Oncol Res Treat; 2018; 41(4):181-186. PubMed ID: 29562225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esterase-responsive and size-optimized prodrug nanoparticles for effective intracranial drug delivery and glioblastoma treatment.
    Ye Z; Gao L; Cai J; Wang Y; Li Y; Tong S; Yan T; Sun Q; Qi Y; Xu Y; Jiang H; Zhang S; Zhao L; Zhang S; Chen Q
    Nanomedicine; 2022 Aug; 44():102581. PubMed ID: 35811067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
    Mao J; Meng X; Zhao C; Yang Y; Liu G
    Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.